Level Biotechnology Cash Flow Quality Index
Level Biotechnology cash flow quality index. Level Biotechnology (3118) has a Cash Flow Quality Index of 0.44x as of September 2025. Operating cash flow of NT$11.81 Million is below net income of NT$26.84 Million, suggesting accrual-heavy earnings not yet converted to cash. See Level Biotechnology free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Level Biotechnology (2017–2024)
Cash flow quality index of Level Biotechnology from 2017 to 2024. Historical Cash Flow Quality Index for Level Biotechnology across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Level Biotechnology to assess how comfortably operating cash covers total debt obligations.
Level Biotechnology Cash Flow Quality Index by Year (2017–2024)
Level Biotechnology cash flow quality index by year from 2017 to 2024. Year-by-year earnings quality comparison for Level Biotechnology. For the full cash flow conversion analysis, see Level Biotechnology (3118) cash flow conversion.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.99x | NT$64.10 Million | NT$64.81 Million | ▲ +10.8% |
| 2023 | 0.89x | NT$70.21 Million | NT$78.65 Million | ▲ +0.4% |
| 2022 | 0.89x | NT$65.07 Million | NT$73.16 Million | ▼ -51.6% |
| 2021 | 1.84x | NT$155.95 Million | NT$84.89 Million | ▲ +60.1% |
| 2020 | 1.15x | NT$83.23 Million | NT$72.54 Million | ▼ -50.1% |
| 2019 | 2.30x | NT$109.02 Million | NT$47.40 Million | ▲ +234.3% |
| 2018 | 0.69x | NT$26.77 Million | NT$38.91 Million | ▼ -34.1% |
| 2017 | 1.04x | NT$71.29 Million | NT$68.31 Million | — |